Notice of Meetings, 20279-20280 [2020-07561]

Download as PDF Federal Register / Vol. 85, No. 70 / Friday, April 10, 2020 / Notices development, manufacture, sale, and distribution of upper and lower-limb ¨ ssur Hf. markets prosthetic devices. O and sells its prosthetics throughout the United States through its subsidiary, ¨ ssur Americas Holdings, Inc., which is O headquartered in Foothill Ranch, California. College Park, headquartered in Warren, Michigan, also is engaged in the development, manufacture, sale, and distribution of upper and lower-limb prosthetics. The Relevant Product Market and Market Structure The relevant product market in which to assess the competitive effects of the proposed acquisition is no broader than the development, manufacturing, marketing, distribution, and sale of myoelectric elbows. Myoelectric, or powered, elbows use electromyographic signals and battery-powered motors to control movement of the prosthetic. Myoelectric elbows fit directly on the residual limb and use electrical signals generated by muscles to move the motorized elbow componentry. Myoelectric elbows provide substantial functional advantages over mechanical elbows, such as being easier and more natural to control than mechanical elbows. The relevant geographic area in which to assess the competitive effects of the Acquisition is the United States. The United States has unique regulatory and reimbursement requirements that distinguish it from other countries where myoelectric elbows are sold, and manufacturers require U.S. sales and clinical personnel to support their U.S. clinic customers. The U.S. market for myoelectric elbows is highly concentrated. Respondent College Park is a leading supplier of myoelectric elbows and ¨ ssur is currently Respondent O developing its own myoelectric elbow. The only other participants in the U.S. myoelectric elbow market are Otto Bock Healthcare North America and Fillauer LLC. lotter on DSKBCFDHB2PROD with NOTICES Effects of the Acqusition Absent a divestiture, the Acquisition is likely to harm customers of myoelectric elbows in the United States. College Park is currently a leading manufacturer of myoelectric elbows in ¨ ssur is the largest the United States. O prosthetic manufacturer in the United States that does not currently offer a myoelectric elbow, but it is developing a myoelectric elbow to enter the market. Absent the Acquisition, the highly concentrated myoelectric elbow market likely would benefit significantly from VerDate Sep<11>2014 18:00 Apr 09, 2020 Jkt 250001 ¨ ssur’s entry and O ¨ ssur would compete O directly for College Park’s customers. Entry Entry into the myoelectric elbow market would not be timely, likely, or sufficient in magnitude, character, and scope to deter or counteract the anticompetitive effects of the proposed Acquisition. De novo entry is unlikely to occur in a timely manner because the time required for product development and market adoption is lengthy, and the only passive and body-powered elbow manufacturers already sell myoelectric elbows. The Consent Agreement The proposed Order would remedy the competitive concerns raised by the ¨ ssur proposed transaction by requiring O to divest to Steeper the worldwide College Park myoelectric elbow business. The divestiture package consists of the following assets and rights: all assets and rights to research, develop, manufacture, market, and sell the College Park myoelectric elbow products, including all related intellectual property and other confidential business information, manufacturing technology, and existing inventory. Steeper will also be hiring several key College Park employees who are essential to the divested business. Additionally, the Order requires that, at ¨ ssur must the request of Steeper, O provide transitional assistance for up to fifteen months following the divestiture date (with an option to extend further with Commission approval). These services include logistical, administrative, and sales and marketing support. The Order also includes other standard terms designed to ensure the viability of the divested business. The provisions of the proposed Consent Agreement position Steeper to become an effective competitor in the market for myoelectric elbows in the United States. Under the Order, College Park is required to divest its myoelectric elbow business no later than ten days from the ¨ ssur. If the close of its acquisition by O Commission determines that Steeper is not an acceptable acquirer, or that the manner of the divestiture is not acceptable, the Order requires College Park to either unwind the sale of rights and assets to Steeper and then divest the assets to a Commission-approved acquirer within 180 days of the date the Order becomes final, or modify the divestiture to Steeper in the manner the Commission determines is necessary to satisfy the requirements of the Order. The Order also requires a monitor to ¨ ssur’s compliance with the oversee O obligations set forth in the Order. If PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 20279 ¨ ssur does not fully comply with the O divestiture and other requirements of the Order, the Commission may appoint a Divestiture Trustee to divest the myoelectric elbow assets and perform ¨ ssur’s other obligations consistent O with the Order. The Order also requires ¨ ssur shall not acquire, without that O providing advance written notification to the Commission, any myoelectric prosthetic elbow manufacturer or product for a period of five years from the date the Order is issued. The purpose of this analysis is to facilitate public comment on the Consent Agreement to aid the Commission in determining whether it should make the Consent Agreement final. This analysis is not an official interpretation of the proposed Consent Agreement and does not modify its terms in any way. By direction of the Commission. April J. Tabor, Acting Secretary. [FR Doc. 2020–07588 Filed 4–9–20; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meetings Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of five AHRQ subcommittee meetings. AGENCY: The subcommittees listed below are part of AHRQ’s Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will be closed to the public. DATES: See below for dates of meetings: 1. Health Care Research and Training (HCRT) Date: May 20–22, 2020 2. Health System and Value Research (HSVR) Date: June 2–3, 2020 3. Healthcare Information Technology Research (HITR) Date: June 3–5, 2020 4. Healthcare Effectiveness and Outcomes Research (HEOR) Date: June 10–11, 2020 5. Healthcare Safety and Quality Improvement Research (HSQR) Date: June 9–11, 2020 ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 5600 Fishers Lane, Rockville, Maryland 20857. SUMMARY: E:\FR\FM\10APN1.SGM 10APN1 20280 Federal Register / Vol. 85, No. 70 / Friday, April 10, 2020 / Notices (To obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.) Jenny Griffith, Acting Committee Management Officer, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 427– 1557. SUPPLEMENTARY INFORMATION: In accordance with section 10 (a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ’s Health Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for these meetings are subject to change as priorities dictate. FOR FURTHER INFORMATION CONTACT: Virginia L. Mackay-Smith, Associate Director, AHRQ. [FR Doc. 2020–07561 Filed 4–9–20; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; National Advisory Committee on the Sex Trafficking of Children and Youth in the United States (NAC) Recommendations and State SelfAssessment Survey (NEW) Office on Trafficking in Persons; Administration for Children and Families; HHS. ACTION: Request for public comment. AGENCY: The Office on Trafficking in Persons (OTIP), Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), is proposing to collect data for a new survey, the National Advisory Committee on the Sex Trafficking of Children and Youth in the United States (NAC) Recommendations and State Self-Assessment Survey. DATES: Comments due within 60 days of publication. In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, ACF is soliciting public comment on the specific aspects of the information collection described above. ADDRESSES: Copies of the proposed collection of information can be obtained and comments may be forwarded by emailing infocollection@ acf.hhs.gov. Alternatively, copies can also be obtained by writing to the SUMMARY: Administration for Children and Families, Office of Planning, Research and Evaluation (OPRE), 330 C Street SW, Washington, DC 20201, Attn: ACF Reports Clearance Officer. All requests, emailed or written, should be identified by the title of the information collection. SUPPLEMENTARY INFORMATION: Description: The Preventing Sex Trafficking and Strengthening Families Act of 2014 mandated the NAC to develop a report describing how each state has implemented its recommendations to address sex trafficking in children and youth. The NAC proposes to administer a survey allowing states to assess their progress in implementing NAC recommendations. Submissions will allow states to document their efforts in the following sections: Multidisciplinary Response, Screening and Identification, Child Welfare, Service Provision, Housing, Law Enforcement and Prosecution, Judiciary, Demand Reduction, Prevention, Legislation and Regulation, Research and Data, and Funding. Each state will have the opportunity to provide a selfassessed tier ranking for each recommendation, a justification of their assessment, sources for their assessment, and the public or private nature of those sources. Respondents: State Governors, Child Welfare Agencies, Local Law Enforcement, and Other Local Agencies. ANNUAL BURDEN ESTIMATES Instrument Total number of respondents contributing for 50 States Total number of responses per respondent Average burden hours per response for individuals in States Average burden hours per State response Total burden hours per individual Annual burden hours 250 1 6.85 34.25 1,713 571 lotter on DSKBCFDHB2PROD with NOTICES NAC Recommendations and State SelfAssessment Survey .............................. Estimated Total Annual Burden Hours: 571. Comments: The Department specifically requests comments on (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the VerDate Sep<11>2014 18:00 Apr 09, 2020 Jkt 250001 use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Authority: 42 U.S.C. 1314b. Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice of supplemental awards. AGENCY: [FR Doc. 2020–07554 Filed 4–9–20; 8:45 am] PO 00000 Health Resources and Services Administration Health Center Program Mary B. Jones, ACF/OPRE Certifying Officer. BILLING CODE 4184–47–P DEPARTMENT OF HEALTH AND HUMAN SERVICES HRSA provided supplemental funding to existing State and Regional Primary Care Association Cooperative Agreements (PCAs) to support enhanced SUMMARY: Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 85, Number 70 (Friday, April 10, 2020)]
[Notices]
[Pages 20279-20280]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07561]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meetings

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of five AHRQ subcommittee meetings.

-----------------------------------------------------------------------

SUMMARY: The subcommittees listed below are part of AHRQ's Health 
Services Research Initial Review Group Committee. Grant applications 
are to be reviewed and discussed at these meetings. Each subcommittee 
meeting will be closed to the public.

DATES: See below for dates of meetings:

1. Health Care Research and Training (HCRT)
    Date: May 20-22, 2020
2. Health System and Value Research (HSVR)
    Date: June 2-3, 2020
3. Healthcare Information Technology Research (HITR)
    Date: June 3-5, 2020
4. Healthcare Effectiveness and Outcomes Research (HEOR)
    Date: June 10-11, 2020
5. Healthcare Safety and Quality Improvement Research (HSQR)
    Date: June 9-11, 2020

ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 
5600 Fishers Lane, Rockville, Maryland 20857.

[[Page 20280]]


FOR FURTHER INFORMATION CONTACT: (To obtain a roster of members, agenda 
or minutes of the non-confidential portions of the meetings.)
    Jenny Griffith, Acting Committee Management Officer, Office of 
Extramural Research Education and Priority Populations, Agency for 
Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, 
Maryland 20857, Telephone (301) 427-1557.

SUPPLEMENTARY INFORMATION: In accordance with section 10 (a)(2) of the 
Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces 
meetings of the above-listed scientific peer review groups, which are 
subcommittees of AHRQ's Health Services Research Initial Review Group 
Committee. The subcommittee meetings will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. App. 2 section 
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant 
applications and the discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Agenda items for these meetings are subject to change as priorities 
dictate.

Virginia L. Mackay-Smith,
Associate Director, AHRQ.
[FR Doc. 2020-07561 Filed 4-9-20; 8:45 am]
 BILLING CODE 4160-90-P